Vaginal microbicides: moving ahead after an unexpected setback
- 30 November 2007
- journal article
- review article
- Published by Wolters Kluwer Health in AIDS
- Vol. 21 (18), 2369-2376
- https://doi.org/10.1097/qad.0b013e3282ef83fd
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- A Comprehensive Murine Model to Evaluate Topical Vaginal Microbicides: Mucosal Inflammation and Susceptibility to Genital Herpes as Surrogate Markers of SafetyThe Journal of Infectious Diseases, 2007
- Trial and failureNature, 2007
- Impact of Microbicides and Sexually Transmitted Infections on Mucosal Immunity in the Female Genital TractAmerican Journal of Reproductive Immunology, 2006
- Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicideInternational Journal of Pharmaceutics, 2006
- Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 TrialPLoS Medicine, 2005
- The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong?PLoS Medicine, 2005
- The Need for a “Condoms-Only” Control Group in Microbicide TrialsEpidemiology, 2003
- Effects of Contraceptive Method on the Vaginal Microbial Flora: A Prospective EvaluationThe Journal of Infectious Diseases, 2000
- Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workersAIDS, 2000
- The Effects of Three Nonoxynol‐9 Preparations on Vaginal Flora and EpitheliumThe Journal of Infectious Diseases, 1999